These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
567 related items for PubMed ID: 22920591
1. Effectiveness of omalizumab in a patient with severe asthma, low serum IgE level, and lack of sensitized allergens induced by oral steroid therapy: the usefulness of impulse oscillation for assessment of omalizumab therapy. Matsuno O, Komori C, Hang Y, Matsumoto T, Minamoto S. J Asthma; 2012 Oct; 49(8):839-42. PubMed ID: 22920591 [Abstract] [Full Text] [Related]
5. Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study. Dal Negro RW, Guerriero M, Micheletto C, Tognella S, Visconti M. J Asthma; 2011 Jun; 48(5):437-41. PubMed ID: 21599560 [Abstract] [Full Text] [Related]
11. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX). Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM, QUALITX Study Investigators. J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355 [Abstract] [Full Text] [Related]
12. Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma. Shimizu Y, Dobashi K, Fueki N, Fueki M, Okada T, Tomioka S, Makino S, Mori M. J Biol Regul Homeost Agents; 2011 Apr; 25(2):177-86. PubMed ID: 21880206 [Abstract] [Full Text] [Related]
13. Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma. Berger W, Gupta N, McAlary M, Fowler-Taylor A. Ann Allergy Asthma Immunol; 2003 Aug; 91(2):182-8. PubMed ID: 12952113 [Abstract] [Full Text] [Related]
15. Plasmapheresis prior to omalizumab administration in a 15-year-old boy with severe asthma and very high IgE levels: sustained effect over 2 years. Kerzel S, Zemlin M, Rogosch T, Ollert M, Renz H, Klaus G, Maier RF. Klin Padiatr; 2011 Nov; 223(6):356-9. PubMed ID: 22012605 [Abstract] [Full Text] [Related]
16. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma. Ayres JG, Higgins B, Chilvers ER, Ayre G, Blogg M, Fox H. Allergy; 2004 Jul; 59(7):701-8. PubMed ID: 15180756 [Abstract] [Full Text] [Related]